Trial Outcomes & Findings for Presumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI) (NCT NCT03885232)

NCT ID: NCT03885232

Last Updated: 2025-04-30

Results Overview

Immunization status was obtained from WA or CO state immunization registry or directly from participating practices. At enrollment, parent/infant dyads completed the Parental Attitudes about Childhood Vaccines short version (PACV-SF), a validated survey scored from 0 to 4. A score of 2 or more represented parent/infant dyad with negative vaccine attitudes. Among parent/infant dyads with negative vaccine attitudes, the child's immunization status at 19 months was calculated based on recommended ages and intervals between doses provided by ACIP for summing late days for each dose of the 8 routine vaccines recommended by 19 months (HepB, rotavirus, DTaP, Hib, pneumococcal conjugate, inactivated polio virus, MMR, and varicella). There was a max of 23 recommended doses for the 8 vaccines - doses varied depending on brand. Total max DUI was a sum of total possible days late for each dose through 19mo(2830 days).Percent DUI was calculated by dividing child's DUI by the total maximum DUI.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

17446 participants

Primary outcome timeframe

Child's immunization status at 19 months of age

Results posted on

2025-04-30

Participant Flow

Unit of analysis: clinics

Participant milestones

Participant milestones
Measure
PIVOT With MI
Clinics in which the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy was implemented.
Control
Clinics delivered standard care.
Overall Study
STARTED
9905 12
7541 12
Overall Study
Participants Are Clinicians
127 12
85 12
Overall Study
Participants Are Parents Within the Parent/Infant Dyads
4889 12
3728 12
Overall Study
Participants Are Infants Within the Parent/Infant Dyads
4889 12
3728 12
Overall Study
COMPLETED
9799 12
7486 12
Overall Study
NOT COMPLETED
106 0
55 0

Reasons for withdrawal

Reasons for withdrawal
Measure
PIVOT With MI
Clinics in which the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy was implemented.
Control
Clinics delivered standard care.
Overall Study
Lost to Follow-up
74
32
Overall Study
Staff turnover at enrolled clinics
32
23

Baseline Characteristics

Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PIVOT With MI
n=9905 Participants
Clinics in which the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy has been implemented.
Control
n=7541 Participants
Care delivered as usual.
Total
n=17446 Participants
Total of all reporting groups
Age, Categorical
Parent/Infant Dyads · <=18 years
0 Participants
n=4889 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
0 Participants
n=3728 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
0 Participants
n=8617 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
Age, Categorical
Parent/Infant Dyads · Between 18 and 65 years
4889 Participants
n=4889 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
3728 Participants
n=3728 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
8617 Participants
n=8617 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
Age, Categorical
Parent/Infant Dyads · >=65 years
0 Participants
n=4889 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
0 Participants
n=3728 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
0 Participants
n=8617 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
Sex/Gender, Customized
Parent/Infant Dyads · Female
4138 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
3200 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
7338 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Sex/Gender, Customized
Parent/Infant Dyads · Male
567 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
425 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
992 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Sex/Gender, Customized
Parent/Infant Dyads · Unknown
184 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
103 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
287 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Sex/Gender, Customized
Clinicians · Female
88 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
61 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
149 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Sex/Gender, Customized
Clinicians · Male
39 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
24 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
63 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Sex/Gender, Customized
Clinicians · Unknown
0 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
0 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
0 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Ethnicity (NIH/OMB)
Parent/Infant Dyads · Hispanic or Latino
551 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
460 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
1011 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Ethnicity (NIH/OMB)
Parent/Infant Dyads · Not Hispanic or Latino
4,162 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
3158 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
7320 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Ethnicity (NIH/OMB)
Parent/Infant Dyads · Unknown or Not Reported
176 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
110 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
286 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Ethnicity (NIH/OMB)
Clinicians · Hispanic or Latino
3 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
5 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
8 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Ethnicity (NIH/OMB)
Clinicians · Not Hispanic or Latino
123 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
79 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
202 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Ethnicity (NIH/OMB)
Clinicians · Unknown or Not Reported
1 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
1 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
2 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Parent/Infant Dyads · American Indian or Alaska Native
62 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
28 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
90 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Parent/Infant Dyads · Asian
228 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
358 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
586 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Parent/Infant Dyads · Native Hawaiian or Other Pacific Islander
14 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
19 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
33 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Parent/Infant Dyads · Black or African American
85 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
63 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
148 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Parent/Infant Dyads · White
3997 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
2931 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
6928 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Parent/Infant Dyads · More than one race
188 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
142 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
330 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Parent/Infant Dyads · Unknown or Not Reported
315 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
187 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
502 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Clinicians · American Indian or Alaska Native
0 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
0 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
0 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Clinicians · Asian
13 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
8 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
21 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Clinicians · Native Hawaiian or Other Pacific Islander
0 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
0 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
0 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Clinicians · Black or African American
0 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
1 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
1 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Clinicians · White
106 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
74 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
180 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Clinicians · More than one race
6 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
2 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
8 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Race (NIH/OMB)
Clinicians · Unknown or Not Reported
2 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
0 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
2 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
Region of Enrollment
United States
9905 participants
n=9905 Participants
7541 participants
n=7541 Participants
17446 participants
n=17446 Participants

PRIMARY outcome

Timeframe: Child's immunization status at 19 months of age

Population: Infants of parents/caregivers who had negative vaccine attitudes (Parental Attitudes about Childhood Vaccines short form (PACV-SF) score of 2 or higher)

Immunization status was obtained from WA or CO state immunization registry or directly from participating practices. At enrollment, parent/infant dyads completed the Parental Attitudes about Childhood Vaccines short version (PACV-SF), a validated survey scored from 0 to 4. A score of 2 or more represented parent/infant dyad with negative vaccine attitudes. Among parent/infant dyads with negative vaccine attitudes, the child's immunization status at 19 months was calculated based on recommended ages and intervals between doses provided by ACIP for summing late days for each dose of the 8 routine vaccines recommended by 19 months (HepB, rotavirus, DTaP, Hib, pneumococcal conjugate, inactivated polio virus, MMR, and varicella). There was a max of 23 recommended doses for the 8 vaccines - doses varied depending on brand. Total max DUI was a sum of total possible days late for each dose through 19mo(2830 days).Percent DUI was calculated by dividing child's DUI by the total maximum DUI.

Outcome measures

Outcome measures
Measure
PIVOT With MI: Parent/Caregiver and Infant Dyad
n=586 Participants
Parent/Caregiver and Infant dyads at participating clinics trained to use the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy.
Control: Parent/Caregiver and Infant Dyad
n=351 Participants
Parent/Caregiver and Infant dyads at participating clinics in the control arm who received care as usual.
Child Immunization Status at 19 Months, 0 Days of Age Characterized as Percent Days Under-immunized (DUI)
32 percentage of days under-immunized
Standard Deviation 38
24 percentage of days under-immunized
Standard Deviation 32

SECONDARY outcome

Timeframe: approximately 6 months post birth

Population: A subset of parent/infant dyads in both intervention and control clinics who were identified as vaccine hesitant (score of 2 or more on the Parental Attitudes about Childhood Vaccines short form (PACV-SF)) and who completed the post-healthcare visit satisfaction survey.

To assess parental satisfaction with their clinician during a health supervision visit, we asked all vaccine hesitant parents (identified by a Parental Attitudes about Childhood Vaccines-Short Form (PAC-V SF) score of 2 or more) in both both intervention and control arms if they would complete an additional 15-question survey over the phone within 24-48 hours after the completion of a health supervision visit for their child around 6 months of age. Due to COVID-19 restrictions, we had to extend the time frame to within 1 week after a health supervision visit at 2, 4, or 6 months of age. Ratings were on a 7-point Likert scale - Very Poor (1), Poor (2), Fair (3), Good (4), Very Good (5), Excellent (6), Outstanding (7). Overall experience with a rating of "Good (4)" or higher was considered to be a satisfactory visit.

Outcome measures

Outcome measures
Measure
PIVOT With MI: Parent/Caregiver and Infant Dyad
n=73 Participants
Parent/Caregiver and Infant dyads at participating clinics trained to use the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy.
Control: Parent/Caregiver and Infant Dyad
n=46 Participants
Parent/Caregiver and Infant dyads at participating clinics in the control arm who received care as usual.
Post-Visit Parental Satisfaction Survey Scored on a 7-point Likert Scale
96 % of participants scoring 4 or higher
96 % of participants scoring 4 or higher

SECONDARY outcome

Timeframe: At Baseline and Post-Intervention (up to 2 years after baseline)

Population: Clinicians enrolled across n=24 clinics (n=12 intervention clinics; n=12 control clinics)

To assess changes in clinicians' perceived self-efficacy when discussing vaccines with parents/infant dyads with negative vaccine attitudes, a survey was administered to all participating clinicians at baseline and at study completion asking about vaccine recommendation behaviors and how they perceived their impact on parental decision making regarding vaccines. Self-efficacy was assessed with a 3-part question scored on a Likert Scale - Strongly Disagree, Somewhat Disagree, Somewhat Agree, Strongly Agree. Changes in perceived self-efficacy over time was assessed by comparing the number of clinicians who answered "Strongly Agree" or "Somewhat Agree" to the statement "When parents wish to delay or refuse childhood vaccines for their child, there is not much I can say to change their minds" at baseline and at post-study. Note that fewer clinicians completed the post-study survey due to such factors as retirement and staff turnover.

Outcome measures

Outcome measures
Measure
PIVOT With MI: Parent/Caregiver and Infant Dyad
n=127 Participants
Parent/Caregiver and Infant dyads at participating clinics trained to use the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy.
Control: Parent/Caregiver and Infant Dyad
n=85 Participants
Parent/Caregiver and Infant dyads at participating clinics in the control arm who received care as usual.
Change in Clinician Self-Efficacy With Parent/Infant Dyads With Negative Vaccine Attitudes - Pre-vs Post-Surveys
Baseline Survey Results
54 Participants
39 Participants
Change in Clinician Self-Efficacy With Parent/Infant Dyads With Negative Vaccine Attitudes - Pre-vs Post-Surveys
Post-Study Survey Results
23 Participants
20 Participants

Adverse Events

PIVOT With MI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sean O'Leary, MD, MPH - Principal Investigator

University of Colorado at Anschutz Medical Campus

Phone: (303)724-1582

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place